Subtopic Deep Dive

Melasma
Research Guide

What is Melasma?

Melasma is a chronic acquired hyperpigmentation disorder characterized by symmetric brown macules on sun-exposed facial areas, primarily affecting women with darker skin types (Handel et al., 2014).

Melasma prevalence reaches 1-50% in endemic areas, driven by UV exposure, hormones, and genetics (Handel et al., 2014; 415 citations). Reviews detail etiologies including female sex hormones and family history, with histologic vascular and pigment changes (Ogbechie-Godec and Elbuluk, 2017; 383 citations; Kwon et al., 2016; 182 citations). Over 3,000 papers exist on melasma treatments like peels and lasers.

15
Curated Papers
3
Key Challenges

Why It Matters

Melasma imposes psychosocial distress, ranking as a top dermatology consultation reason, especially in Latin American women (Handel et al., 2014). Effective therapies address unmet needs in safe, long-term control amid hydroquinone side effects (Sheth and Pandya, 2011; 369 citations). Grimes (1995; 319 citations) established pathogenesis linking sun exposure and pregnancy, guiding peels like salicylic acid (Arif, 2015; 260 citations) and alpha-hydroxy acids (Tang and Yang, 2018; 182 citations) for clinical practice.

Key Research Challenges

Hydroquinone Resistance

Hydroquinone, the gold standard, causes irritation and rebound pigmentation in 20-30% of cases (Sheth and Pandya, 2011). Long-term safety concerns drive need for alternatives like cysteamine (Ogbechie-Godec and Elbuluk, 2017). Vascular components complicate epidermal-only treatments (Kwon et al., 2016).

Heterogeneous Histology

Melasma shows epidermal, dermal, and mixed melanin plus vascular changes, hindering uniform therapy (Kwon et al., 2016; 182 citations). Inflammatory processes persist post-treatment (Lee, 2015; 195 citations). Subtype-specific responses vary by 40-60% (Grimes, 1995).

Recurrence After Treatment

Relapse rates exceed 50% within one year due to UV and hormonal triggers (Handel et al., 2014). Peels like salicylic acid offer short-term gains but lack durability (Arif, 2015). Combination regimens underexplored (Tang and Yang, 2018).

Essential Papers

1.

Acne Scars: Pathogenesis, Classification and Treatment

Gabriella Fabbrocini, Maria Carmela Annunziata, V. D′Arco et al. · 2010 · Dermatology Research and Practice · 416 citations

Acne has a prevalence of over 90% among adolescents and persists into adulthood in approximately 12%–14% of cases with psychological and social implications. Possible outcomes of the inflammatory a...

2.

Melasma: a clinical and epidemiological review

Ana Carolina Handel, Luciane Donida Bartoli Miot, Hélio Amante Miot · 2014 · Anais Brasileiros de Dermatologia · 415 citations

Melasma is a chronic acquired hypermelanosis of the skin, characterized by irregular brown macules symmetrically distributed on sun-exposed areas of the body, particularly on the face. It is a comm...

3.

Melasma: an Up-to-Date Comprehensive Review

Oluwatobi A. Ogbechie-Godec, Nada Elbuluk · 2017 · Dermatology and Therapy · 383 citations

Melasma is a common acquired condition of symmetric hyperpigmentation, typically occurring on the face, with higher prevalence in females and darker skin types. Multiple etiologies, including light...

4.

Melasma: A comprehensive update

Vaneeta M. Sheth, Amit G. Pandya · 2011 · Journal of the American Academy of Dermatology · 369 citations

5.

Melasma

Pearl E. Grimes · 1995 · Archives of Dermatology · 319 citations

<h3>Background:</h3> Melasma is a common acquired symmetric hypermelanosis characterized by irregular light- to gray-brown macules and patches involving sunexposed areas of skin. Etiologic factors ...

6.

Salicylic acid as a peeling agent: a comprehensive review

Tasleem Arif · 2015 · Clinical Cosmetic and Investigational Dermatology · 260 citations

Salicylic acid has been used to treat various skin disorders for more than 2,000 years. The ability of salicylic acid to exfoliate the stratum corneum makes it a good agent for peeling. In particul...

7.

Arterial embolization caused by injection of hyaluronic acid (RestylaneR)

Stefan Schanz, Wilfried Schippert, Anja Ulmer et al. · 2002 · British Journal of Dermatology · 215 citations

Journal Article Arterial embolization caused by injection of hyaluronic acid (Restylane®) Get access S. Schanz, S. Schanz Department of Dermatology, University Hospital Tübingen, Liebermeisterstraß...

Reading Guide

Foundational Papers

Start with Grimes (1995; 319 citations) for etiology basics, then Sheth and Pandya (2011; 369 citations) for treatment update, Handel et al. (2014; 415 citations) epidemiology.

Recent Advances

Ogbechie-Godec and Elbuluk (2017; 383 citations) comprehensive review; Kwon et al. (2016; 182 citations) pathology heterogeneity; Lee (2015; 195 citations) pathogenesis.

Core Methods

Hydroquinone combos, salicylic peels (Arif, 2015), alpha-hydroxy acids (Tang and Yang, 2018), addressing vascular changes (Kwon et al., 2016).

How PapersFlow Helps You Research Melasma

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to query 'melasma treatment alternatives hydroquinone,' surfacing Handel et al. (2014; 415 citations) and Kwon et al. (2016). citationGraph reveals pathogenesis clusters from Grimes (1995) to Lee (2015), while findSimilarPapers expands to peels from Arif (2015).

Analyze & Verify

Analysis Agent applies readPaperContent to extract histologic data from Kwon et al. (2016), then verifyResponse with CoVe checks claims against Grimes (1995). runPythonAnalysis processes pigmentation scores from 10 papers via pandas for meta-analysis, with GRADE grading assigning high evidence to Sheth and Pandya (2011) reviews.

Synthesize & Write

Synthesis Agent detects gaps in dermal melasma therapies via contradiction flagging between Lee (2015) and Tang (2018). Writing Agent uses latexEditText, latexSyncCitations for treatment protocols, and latexCompile for publication-ready reviews with exportMermaid diagrams of pathogenesis pathways.

Use Cases

"Compare salicylic acid peels vs. lasers for melasma recurrence rates"

Research Agent → searchPapers('melasma peels lasers') → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Arif 2015 + Sheth 2011) → GRADE report with 95% CI recurrence stats.

"Draft LaTeX review on melasma pathogenesis updates"

Synthesis Agent → gap detection (Lee 2015 vs Kwon 2016) → Writing Agent → latexEditText + latexSyncCitations(Handel 2014, Grimes 1995) → latexCompile → PDF with cited figures.

"Find code for melasma pigment quantification from papers"

Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for image-based melanin analysis.

Automated Workflows

Deep Research workflow scans 50+ melasma papers via searchPapers → citationGraph → structured report on subtypes (Kwon et al., 2016). DeepScan applies 7-step CoVe to verify peel efficacy claims from Arif (2015) against Tang (2018). Theorizer generates hypotheses on vascular-targeted therapies from Lee (2015) inflammation data.

Frequently Asked Questions

What defines melasma?

Melasma is symmetric brown macules on sun-exposed face from UV, hormones, genetics (Handel et al., 2014; Grimes, 1995). Affects 15-50% darker-skinned women.

What are main treatment methods?

Topicals (hydroquinone, alternatives), chemical peels (salicylic acid; Arif, 2015), lasers. Triple combination cream standard (Sheth and Pandya, 2011).

What are key papers?

Handel et al. (2014; 415 citations) epidemiology; Ogbechie-Godec (2017; 383) review; Grimes (1995; 319) foundational pathogenesis.

What open problems exist?

Dermal melasma resistance, >50% recurrence, heterogeneous pathology needing targeted combos (Kwon et al., 2016; Lee, 2015).

Research Dermatologic Treatments and Research with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Melasma with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers